Our top pick for
The Andersons Inc is a food distribution business based in the US. The Andersons shares (ANDE) are listed on the NASDAQ and all prices are listed in US Dollars. The Andersons employs 2,229 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$31.23|
|52-week range||$17.58 - $34.03|
|50-day moving average||$30.42|
|200-day moving average||$29.63|
|Wall St. target price||$36.00|
|Dividend yield||$0.7 (2.24%)|
|Earnings per share (TTM)||$2.19|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-2.16%|
|1 month (2021-09-17)||6.55%|
|3 months (2021-07-16)||17.72%|
|6 months (2021-04-16)||8.48%|
|1 year (2020-10-16)||34.90%|
|2 years (2019-10-16)||70.56%|
|3 years (2018-10-16)||35.34|
|5 years (2016-10-14)||36.7|
Valuing The Andersons stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Andersons's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Andersons's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, The Andersons shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Andersons's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Andersons's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Andersons's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $314.4 million.
The EBITDA is a measure of a The Andersons's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$10.4 billion|
|Operating margin TTM||1.2%|
|Gross profit TTM||$404.9 million|
|Return on assets TTM||2.12%|
|Return on equity TTM||6.47%|
|Market capitalisation||$1 billion|
TTM: trailing 12 months
There are currently 334,859 The Andersons shares held short by investors – that's known as The Andersons's "short interest". This figure is 22% down from 429,103 last month.
There are a few different ways that this level of interest in shorting The Andersons shares can be evaluated.
The Andersons's "short interest ratio" (SIR) is the quantity of The Andersons shares currently shorted divided by the average quantity of The Andersons shares traded daily (recently around 133409.96015936). The Andersons's SIR currently stands at 2.51. In other words for every 100,000 The Andersons shares traded daily on the market, roughly 2510 shares are currently held short.
However The Andersons's short interest can also be evaluated against the total number of The Andersons shares, or, against the total number of tradable The Andersons shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Andersons's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 The Andersons shares in existence, roughly 10 shares are currently held short) or 0.011% of the tradable shares (for every 100,000 tradable The Andersons shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Andersons.
Find out more about how you can short The Andersons stock.
Dividend payout ratio: 31.82% of net profits
Recently The Andersons has paid out, on average, around 31.82% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Andersons shareholders could enjoy a 2.24% return on their shares, in the form of dividend payments. In The Andersons's case, that would currently equate to about $0.7 per share.
While The Andersons's payout ratio might seem fairly standard, it's worth remembering that The Andersons may be investing much of the rest of its net profits in future growth.
The Andersons's most recent dividend payout was on 21 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2021 (the "ex-dividend date").
The Andersons's shares were split on a 3:2 basis on 18 February 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your The Andersons shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for The Andersons shares which in turn could have impacted The Andersons's share price.
Over the last 12 months, The Andersons's shares have ranged in value from as little as $17.5799 up to $34.0258. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Andersons's is 0.6688. This would suggest that The Andersons's shares are less volatile than average (for this exchange).
The Andersons, Inc. , an agriculture company, operates in trade, ethanol, plant nutrient, and rail sectors in the United States and internationally. The company's Trade segment operates grain elevators; stores grains; and provides grain marketing, risk management, and corn origination services to its customers and affiliated ethanol facilities. This segment also engages in the commodity merchandising business. Its Ethanol segment purchases and sells ethanol, as well as offers facility operations, risk management, and ethanol and coproducts marketing services to the ethanol plants it invests in and operates. The company's Plant Nutrient segment manufactures, distributes, and retails agricultural and related plant nutrients, and pelleted lime and gypsum products; and crop nutrients, crop protection chemicals, and seed products, as well as provides application and agronomic services to commercial and family farmers. It also offers warehousing, packaging, and manufacturing services to nutrient producers and other distributors; and manufactures and distributes various industrial products, such as nitrogen reagents for air pollution control systems that are used in coal-fired power plants, and water treatment and dust abatement products.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.